Zymedi揭示新型KARS1抑制剂,靶向癌症转移治疗
Zymedi describes new KARS1 inhibitors for cancer metastasis
生物技术与制药领域的最新动态
Zymedi describes new KARS1 inhibitors for cancer metastasis
Adlai Nortye discloses new PROTACs for STAT protein degradation
Beijing Tide Pharmaceutical reports ATR kinase inhibitors
Sichuan Kelun-Biotech Biopharmaceutical discovers new ADCs targeting CDH3
Insilico Medicine presents new KIF18A inhibitors
Holiday notice
In the clinic for Feb. 13, 2026
Other news to note for Feb. 13, 2026
Regulatory actions for Feb. 13, 2026
Money raised by biopharma
Biopharma money raised: Jan. 1-Feb. 12, 2026
Quantx raises $85M to advance oral immunology drugs
NME Digest: Q4 2025
New CBL-B inhibitors reported in Aurigene Oncology patent
Nanjing Anji Biotechnology synthesizes new OGDH inhibitors
Salubris Pharma divulges new dual ETA/AT1 antagonists
Financings for Feb. 12, 2026
In the clinic for Feb. 12, 2026
Other news to note for Feb. 12, 2026
Regulatory actions for Feb. 12, 2026